Reuters Health

• English Study Finds 50-60% Reduced Risk of COVID for Double-Vaccinated Fully-vaccinated people have an around 50 to 60% reduced risk of infection from the Delta coronavirus variant, including those who are asymptomatic, a large English coronavirus prevalence study found on Wednesday.
  Reuters Health Information, August 04, 2021
• AAIC 2021 Biogen, Eisai Report Design of Real-World Study of Alzheimer's Treatment Biogen and partner Eisai on Thursday revealed the design of an upcoming study of their controversial Alzheimer's treatment, Aduhelm.
  Reuters Health Information, July 30, 2021
• Fluoxetine Doesn't Reduce Depression During Stroke Recovery Adults recovering from a stroke don't appear to have a lower risk of clinically significant depression symptoms when they're prescribed fluoxetine hydrochloride during their recovery, a clinical trial suggests.
  Reuters Health Information, August 02, 2021
• Lambda Variant Shows Vaccine Resistance The Lambda variant of the coronavirus, first identified in Peru and now spreading in South America, is highly infectious and more resistant to vaccines than the original version of the virus, say researchers.
  Reuters Health Information, August 02, 2021
• Third mRNA Dose May Boost Antibody Quantity, but Not Quality Among fully vaccinated people who never had COVID-19, getting a third dose of an mRNA vaccine from Pfizer/BioNTech or Moderna would likely increase levels of antibodies, Rockefeller University researchers report.
  Reuters Health Information, August 02, 2021
• US Senator Lindsey Graham Says He Tested Positive for COVID-19 Republican US Senator Lindsey Graham announced on Monday that he has tested positive for COVID-19 despite being vaccinated, has flu-like symptoms and will be self-quarantining for 10 days.
  Reuters Health Information, August 02, 2021
• Germany to Offer Booster Against COVID-19, Vaccines for Children Germany will in September start to offer a booster shot against COVID-19 to vulnerable individuals such as pensioners and people with weak immune systems.
  Reuters Health Information, August 02, 2021
• Perioperative SOX Protocol Bests Adjuvant CapOx in Locally Advanced Gastric Cancer In patients who had a D2 gastrectomy, perioperative administration of the oral fluoropyrimidine derivative S-1 and oxaliplatin yielded better outcomes than adjuvant capecitabine and oxaliplatin in a phase 3 trial.
  Reuters Health Information, August 02, 2021
• Smoke-Free Vehicles Tied to Fewer Early Childhood Asthma Hospitalizations Fewer children in Scotland are being admitted to the hospital for asthma exacerbations since the implementation of a law banning smoking in vehicles carrying children, a new study suggests.
  Reuters Health Information, August 02, 2021
• Olympic Athletes Battle Tokyo Summer as Staff Suffer Heat Illness As competitors battled for the podium on the third day of Olympic athletics on Sunday, it was Tokyo's oppressive heat that perhaps dished out the most pain.
  Reuters Health Information, August 02, 2021
• Abbott Labs to Pay $160 Mln Over Kickbacks, False Diabetes Claims to Medicare Abbott Laboratories will pay $160 million to resolve claims that two of its units submitted false claims to Medicare by providing kickbacks to diabetes patients, including 'free or 'no cost' glucose monitors, the US Department of Justice said.
  Reuters Health Information, August 02, 2021
• Hair Shedding Related to COVID-19 Doesn't Last Long Acute telogen effluvium following COVID-19 appears to occur sooner, with quicker resolution, than when it is triggered by other events, clinicians have observed.
  Reuters Health Information, August 02, 2021
• Pesticides, Common Chemicals Could Raise Breast Cancer Risk Nearly 300 chemicals found in everything from pesticides to food additives, cosmetics, and even water could be increasing the risk of breast cancer in American women, a new study shows.
  Reuters Health Information, July 30, 2021
• Out-of-Pocket Costs for MRI Breast Cancer Screening Hitting More Women Increasing numbers of women who need MRI screening for breast cancer are being hit by high out-of-pocket costs, a new study finds.
  Reuters Health Information, July 30, 2021
• Different IV Bisphosphonates Tied to Similar Skeletal Event Rate The risk of recurrent skeletal-related events in patients with multiple myeloma is similar with IV bisphosphonate dosing schedules ranging from 4 weeks to longer than 12 weeks, a new study suggests.
  Reuters Health Information, July 30, 2021
• Protein Profiles May Predict Stable, Progressive Chronic Lymphocytic Leukemia Protein profiles identified through proteomics in early-stage chronic lymphocytic leukemia show promise in discriminating between stable and progressive disease, researchers suggest.
  Reuters Health Information, July 30, 2021
• Postdiagnosis Smoking Cessation Tied to Improved Lung Cancer Outcomes Current smokers who quit after they're diagnosed with early-stage lung cancer have better overall and progression-free survival than counterparts who continue smoking, a small study suggests.
  Reuters Health Information, July 30, 2021
• HER2-Low-Positive Breast Cancer a Distinct Subgroup That Behaves Differently HER2-low-positive breast cancer, readily identified by standardized central pathology, is a distinct subtype with a specific biology and different response to therapy and prognosis, report researchers in Germany.
  Reuters Health Information, July 30, 2021
• Stepped-Care Approach to CBT for Insomnia in Cancer Patients Works For cancer-related insomnia, a stepped-care approach to delivering cognitive-behavioral therapy for insomnia (CBT-I) may work as well as standard CBT-I, according to a study from Canada.
  Reuters Health Information, July 30, 2021
• Long-Term Complications From Subcutaneous ICDs Assessed Using real-world patient data, researchers documented long-term complications from subcutaneous implantable cardioverter defibrillators.
  Reuters Health Information, July 30, 2021